Literature DB >> 16982917

TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs.

Analía V Ezernitchi1, Ilan Vaknin, Leonor Cohen-Daniel, Ofer Levy, Efrat Manaster, Amal Halabi, Eli Pikarsky, Lior Shapira, Michal Baniyash.   

Abstract

T cell AgR zeta chain down-regulation associated with T cell dysfunction has been described in cancer, infectious, and autoimmune diseases. We have previously shown that chronic inflammation is mandatory for the induction of an immunosuppressive environment leading to this phenomenon. To identify the key immunosuppressive components, we used an in vivo mouse model exhibiting chronic inflammation-induced immunosuppression. Herein, we demonstrate that: 1) under chronic inflammation secondary lymphatic organs display various immunological milieus; zeta chain down-regulation and T cell dysfunction are induced in the spleen, peripheral blood, and bone marrow, but not in lymph nodes, correlating with elevated levels of Gr1(+)Mac-1(+) myeloid suppressor cells (MSC); 2) MSC are responsible for the induction of such an immunosuppression under both normal and inflammatory conditions; and 3) normal T cells administered into mice exhibiting an immunosuppressive environment down-regulate their zeta expression. Such an environment is anticipated to limit the success of immunotherapeutic strategies based on vaccination and T cell transfer, which are currently under investigation for immunotherapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982917     DOI: 10.4049/jimmunol.177.7.4763

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  Involvement of Gr-1 dull+ cells in the production of TNF-α and IL-17 and exacerbated systemic inflammatory response caused by lipopolysaccharide.

Authors:  Daiki Tanno; Yukiko Akahori; Masahiko Toyama; Ko Sato; Daisuke Kudo; Yuzuru Abe; Tomomitsu Miyasaka; Hideki Yamamoto; Keiko Ishii; Emi Kanno; Ryoko Maruyama; Shigeki Kushimoto; Yoichiro Iwakura; Kazuyoshi Kawakami
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Amplification of functional myeloid-derived suppressor cells during stem cell mobilization induced by granulocyte colony-stimulation-factor.

Authors:  Xiao-Jian Zhu; Jing Hu; Li Sun; Yin Xiao; Zhi-Chao Chen; Yong You; Ping Zou; Hong-Xiang Wang; Zhao-Dong Zhong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

3.  Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function.

Authors:  Eva Sahakian; John J Powers; Jie Chen; Susan L Deng; Fengdong Cheng; Allison Distler; David M Woods; Jennifer Rock-Klotz; Andressa L Sodre; Je-In Youn; Karrune V Woan; Alejandro Villagra; Dmitry Gabrilovich; Eduardo M Sotomayor; Javier Pinilla-Ibarz
Journal:  Mol Immunol       Date:  2014-08-23       Impact factor: 4.407

Review 4.  Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.

Authors:  Suzanne Ostrand-Rosenberg; Pratima Sinha; Daniel W Beury; Virginia K Clements
Journal:  Semin Cancer Biol       Date:  2012-02-01       Impact factor: 15.707

Review 5.  Immune regulation by non-lymphoid cells in transplantation.

Authors:  A-S Dugast; B Vanhove
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

Review 6.  Myeloid-derived suppressor cells: a double-edged sword?

Authors:  Agnieszka Pastuła; Janusz Marcinkiewicz
Journal:  Int J Exp Pathol       Date:  2011-02-12       Impact factor: 1.925

Review 7.  Myeloid derived-suppressor cells: their role in cancer and obesity.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  2018-03-13       Impact factor: 7.486

Review 8.  Regulatory myeloid cells in transplantation.

Authors:  Brian R Rosborough; Dàlia Raïch-Regué; Heth R Turnquist; Angus W Thomson
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

Review 9.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Tumor microenvironment and myeloid-derived suppressor cells.

Authors:  Viktor Umansky; Alexandra Sevko
Journal:  Cancer Microenviron       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.